Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CaPre in Mild-to-High Hypertriglyceridemia (TRIFECTA)
NCT01455844Phase 2Completed
- Sponsor
- Grace Therapeutics, Inc.
- Start
- Sep 2011
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CaPre in hypertriglyceridemia, sponsored by Grace Therapeutics, Inc.. Started Sep 2011; status: completed.
02
Drugs
CaPre
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT01455844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01455844.